Maziar Mike Doustdar to Succeed Lars Fruergaard Jørgensen as Novo Nordisk CEO in August

Bagsværd, Denmark, July 29, 2025 (Globe Newswire) -- Novo Nordisk has announced the appointment of Maziar Mike Doustdar as its new president and chief executive officer, effective August 7, 2025, succeeding Lars Fruergaard Jørgensen. Doustdar, currently serving as executive vice president of International Operations, brings decades of leadership experience within the company and has overseen a period of significant expansion, more than doubling international sales over the past ten years. His appointment, the result of a rigorous selection process that considered both internal and external candidates, signals a continued commitment to bold growth and global leadership in diabetes and obesity treatment.

Read full article here.